CDE Catalog | NINDS Common Data Elements

***Please contact the NINDS CDE Team (NINDSCDE@emmes.com) if you encounter any search difficulties.***

The CDE Catalog is a directory of the available NINDS CDEs. Users can search the Catalog to isolate a subset of the CDEs (e.g., all stroke-specific CDEs, etc.), and to view and download details about the CDEs.

Select any filter below to search the CDE Catalog.

For best results, clear form between searches. In addition, when specifying NeuroRehab, Sport-Related Concussion (SRC) or Traumatic Brain Injury (TBI) as the Disease, please select a Subdisease as well.

NeuroRehab Comprehensive includes all NeuroRehab CDE recommendations. NeuroRehab General includes all NeuroRehab CDE recommendations that are not disease specific. All other NeuroRehab Subdiseases include recommendations specific to existing NINDS CDE project disorders.

Choose your Time Frame for your SRC study (Acute (time of injury until 72 hours), Subacute (after 72 hours to 3 months), and Persistent/Chronic (3 months and greater post-concussion) or Comprehensive if your study falls across the study time frames.

Choose your type of TBI study (Acute Hospitalized, Concussion/Mild TBI, Moderate/Severe TBI: Rehabilitation, or Epidemiology) or Comprehensive if your study falls outside of the study types or incorporates aspects of more than one type of study.

Search Form

Subdomain Name

CRF Name

Displaying 26 - 50 of 755

« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »

Operations

Selected 25 rows in this page.

The search results below can be downloaded by clicking the checkboxes on the far left side of the table. Select the header checkbox to select all CDEs listed on the first page. Then choose CDE Detailed Report from the Choose an operation dropdown menu.
Select all	CDE ID	CDE Name	Definition	Classification	CRF Name	Copyrighted or trademarked	Disease Name	Subdisease Name
F0004-C02311	C02311	Adverse event MedDRA lowest level term code	Code that corresponds to the Medical Dictionary for Regulatory Activities (MedDRA) Lowest Level Term (LLT) for an adverse event	Supplemental	Serious Adverse Events	0	General (For all diseases)	General (For all diseases)
F0004-C18659	C18659	Unexpected adverse event indicator	Indicator of whether the adverse event is unexpected	Supplemental	Serious Adverse Events	0	General (For all diseases)	General (For all diseases)
F0004-C20392	C20392	Serious adverse event treatment description text	The free-text field that describes the interventions specific to the serious adverse event	Supplemental	Serious Adverse Events	0	General (For all diseases)	General (For all diseases)
F0004-C20393	C20393	Serious adverse event start date and time	Date (and time, if applicable and known) on which the serious adverse event was first evident	Supplemental	Serious Adverse Events	0	General (For all diseases)	General (For all diseases)
F0004-C20394	C20394	Serious adverse event end date and time	Date (and time, if applicable and known) on which the serious adverse event discontinued/stopped	Supplemental	Serious Adverse Events	0	General (For all diseases)	General (For all diseases)
F0004-C20395	C20395	Serious adverse event laboratory data text	The free-text field that describes the relevant tests or laboratory data specific to the serious adverse event	Supplemental	Serious Adverse Events	0	General (For all diseases)	General (For all diseases)
F0004-C20396	C20396	Serious adverse event concomitant medication text	The free-text field that describes the concomitant medications taken specific to the serious adverse event	Supplemental	Serious Adverse Events	0	General (For all diseases)	General (For all diseases)
F0004-C20397	C20397	Serious adverse event relevant history text	The free-text field that describes relevant history including pre-existing medical conditions specific to the serious adverse event	Supplemental	Serious Adverse Events	0	General (For all diseases)	General (For all diseases)
F0004-C20398	C20398	Serious adverse event study intervention administration text	The free-text field to describe the administration of study intervention	Supplemental	Serious Adverse Events	0	General (For all diseases)	General (For all diseases)
F0004-C20399	C20399	Serious adverse event end study intervention indicator	Indicator of whether the study intervention was discontinued due to the serious adverse event	Supplemental	Serious Adverse Events	0	General (For all diseases)	General (For all diseases)
F0004-C20400	C20400	Serious adverse event resolve end study intervention indicator	Indicator of whether a serious adverse event ended after the study intervention was stopped	Supplemental	Serious Adverse Events	0	General (For all diseases)	General (For all diseases)
F0004-C20401	C20401	Serious adverse event reappearance restart study intervention indicator	Indicator of whether the adverse event reappeared after the study intervention was restarted	Supplemental	Serious Adverse Events	0	General (For all diseases)	General (For all diseases)
F0004-C20402	C20402	Study blind broken indicator	Indicator of whether the study blind was broken	Supplemental	Serious Adverse Events	0	General (For all diseases)	General (For all diseases)
F0004-C20403	C20403	Serious adverse event investigator assessment reason	Reason in the opinion of the principal investigator that is attributed as the cause of the serious adverse event	Supplemental	Serious Adverse Events	0	General (For all diseases)	General (For all diseases)
F0004-C20404	C20404	Serious adverse event investigator assessment concurrent disorder specify text	The free-text field to specify the concurrent disorder that might have caused the serious adverse event, in the opinion of the principal investigator	Supplemental	Serious Adverse Events	0	General (For all diseases)	General (For all diseases)
F0004-C20405	C20405	Serious adverse event anticipate indicator	Indicator of whether the serious adverse event was anticipated	Supplemental	Serious Adverse Events	0	General (For all diseases)	General (For all diseases)
F0004-C20406	C20406	Serious adverse event comment text	The free-text field to provide any additional information that pertains to the serious adverse event	Supplemental	Serious Adverse Events	0	General (For all diseases)	General (For all diseases)
F0004-C20407	C20407	Adverse event report identifier name	Name of an authorized group or person reporting the adverse event	Supplemental	Serious Adverse Events	0	General (For all diseases)	General (For all diseases)
F0004-C20408	C20408	Serious adverse event report type	Type of report being completed for the serious adverse event	Supplemental	Serious Adverse Events	0	General (For all diseases)	General (For all diseases)
F0004-C20409	C20409	Adverse event sponsor attribution indicator	Indicator of whether the adverse event was caused by the study intervention in question, based on the sponsor's assessment	Supplemental	Serious Adverse Events	0	General (For all diseases)	General (For all diseases)
F0004-C20413	C20413	Serious adverse event investigator assessment concomitant medication specify text	The free-text field to specify the concomitant medication that might have caused the serious adverse event, in the opinion of the principal investigator	Supplemental	Serious Adverse Events	0	General (For all diseases)	General (For all diseases)
F0004-C20414	C20414	Serious adverse event investigator assessment intervention withdrawal specify text	The free-text field to specify the details of the withdrawal of study intervention that might have caused the serious adverse event, in the opinion of the principal investigator	Supplemental	Serious Adverse Events	0	General (For all diseases)	General (For all diseases)
F0004-C20415	C20415	Serious adverse event report complete date	Date when the report on the serious adverse event was completed	Supplemental	Serious Adverse Events	0	General (For all diseases)	General (For all diseases)
F0005-C14123	C14123	Country of residence name	Country where the participant/subject currently lives	Supplemental	Participant/Subject Contact Information	False	General (For all diseases)	General (For all diseases)
F0005-C21117	C21117	Subject name	Name of subject/participant	Supplemental	Participant/Subject Contact Information	False	General (For all diseases)	General (For all diseases)

Displaying 26 - 50 of 755

« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »

The NINDS CDE Team does not post proprietary instruments/scales recommended by the CDE Working Groups on this website. This includes, but is not limited to, copyrighted or trademarked instruments/scales. Information about recommended instruments can be found in the Notice of Copyright (NOC) documents under ‘CRF Module/Guideline’ on each disorder’s data standards page. For any questions regarding these instruments/scales please contact the corresponding owner/author. The NINDS CDE Team is not responsible for the availability or content of these external sites, nor does the NINDS CDE Team endorse, warrant or guarantee the products, services or information described or offered at these other internet sites.